Brief: Skinbiotherapeutics Expect To Be Cash Flow Positive From 2025 On Annual Basis
Dec 4 (Reuters) - SkinBioTherapeutics PLC SBTX.L :
* SKINBIOTHERAPEUTICS PLC: EXPECT TO BE CASH FLOW POSITIVE
FROM
FY2025 ON AN ANNUAL BASIS
Source text: ID:nRSD8480Oa
Further company coverage: SBTX.L
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Skinbiotherapeutics
See all newsBrief: SkinBioTherapeutics Appoints Rachel Parsonage As CEO & Alyson Levett As Chair On Permanent Basis
SkinBioTherapeutics - Trading Statement
Brief: SkinBioTherapeutics Appoints Anita Slater To Start As Interim CFO
SkinBioTherapeutics - Appointment of Interim CFO
SkinBioTherapeutics - Holding(s) in Company